Defining the mechanisms and control of human regulatory T cell function in autoimmunity.
Prof. Graham Lord
King’s College London
Determining an important functional role for integrins in regulating immune responses in IBD
Prof. Mark Travis
University of Manchester
Progressing from genetics to function and clinical translation in Crohn’s disease & ulcerative colitis
Dr Miles Parkes
University of Cambridge
GEM – Genetic, environmental, microbial project
Dr Miles Parkes
University of Cambridge
The PREdiCCt (The PRognostic effect of Environmental factors in Crohn’s and Colitis) Study
Prof. Charlie Lees
University of Edinburgh
Genetics and metagenome studies in orofacial granulomatosis
Dr Natalie Prescott
King’s College London
PANTS – Genetics of immunogenicity to anti-TNF drugs
Dr Tariq Ahmed
University of Exeter
Mechanism linking NOD2 with MHC class I antigen presentation
Prof. Alison Simmons
University of Oxford
CMV infection in inflammatory bowel disease
Prof. Holm Uhlig
University of Oxford
Crohn’s Anal Fistula Quality of Life Scale
Dr Ailsa Hart
London NW Healthcare NHS Trust
IBD-Boost Survey: fatigue pain and urgency in IBD
Prof. Christine Norton
King’s College London
Understanding contributions of T cell determining factors in the pathogenesis of IBD
Prof Adrian Hayday
King’s College London
IBD Risk Alleles – Effect of genetic variants associated with risk for inflammatory disease on immune cell phenotype and function.
Dr Carl Anderson
Wellcome Sanger Institute
Determining the role of HLA variation in Inflammatory Bowel Disease
Prof Jack Satsangi
University of Oxford
MODULATE (Management of diarrhoea in ulcerative colitis)
Prof. Alexander Ford
Leeds Institute of Medical Research (LIMR), St James’ University Hospital
A longitudinal study of childlessness in women with IBD using the UK IBD BioResource
Dr Christian Selinger
Leeds Teaching Hospitals, St James University Hospital
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn’s Disease (ClinicalTrials.gov Identifier: NCT03599622)
Dr Tim Raine
Cambridge University Hospitals NHS Foundation Trust
Using Saliva to PredIcT Crohn’s disease
Prof Laurence Lovat
University College London
Predicting the behaviour of Crohn’s disease using MRI and ultrasound
Dr Stuart Taylor
University College London
The effects of the microbiome on the B cell receptor repertoire in patients with Ulcerative Colitis.
Prof Ken Smith
University of Cambridge
CLARITY- ImpaCt of bioLogic therApy on saRs-CoV-2 infection and immuniTY in inflammatory bowel disease.
Dr Tariq Ahmed
University of Exeter
Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patient
Professor Graham Lord
King’s College London
IBD drug therapies and COVID-19
Dr Nick Kennedy
GlyHealth-COVID: A precision medicine test to identify ImmunoFrail patients at high risk of becoming severely ill or dying from COVID-19
Dr Daniel Spencer
Ludger Ltd. Oxford
SARS-CoV2 Vaccine Immunogenicity in immunosuppressed IBD Patients
Dr Nick Powell
Imperial College London
Clinical Burden of Refractory Proctitis
Dr Gordon W Moran
Nottingham University Hospitals NHS Trust
Risk factors of chronic pain in patients with Inflammatory bowel disease
Prof Qasim Aziz
Wingate Institute for Neurogastroenterology
Generation of IBD gene expression signatures from the INCEPTION cohort to support disease understanding and discovery of novel therapeutic approaches
Dr David Michalovich
BenevolentAI
Dissecting autoimmunity in Crohn’s disease
Dr Ghita Ghislat
Imperial College London
Pilot clinical study on the beta prototype of GlyHealth-IBD – a prognostic and predictive biomarker for inflammatory bowel disease (IBD)
Dr Daryl L Fernandes
Avenna Ltd and Ludger Ltd
Defining the impact of IL2RA genetic polymorphism on human immune cell function in ulcerative colitis
Dr Peter Irving
Guys and St Thomas’s Hospital
Evaluating the Application of Haematopoietic Stem-Cell Gene Therapy as a Novel Therapeutic for Crohn’s Disease patients with Loss-of Function NOD2 Polymorphisms
Dr Piv Sagoo
Orchard Therapeutics Ltd
Functional evaluation of autophagy associated genetic variants in immune cell function in IBD
Dr Yashaswini Kannan
GSK
Last Updated on
